Biotechnology
AGC Biologics Shifts Leadership Structure at United States and Copenhagen Sites to Support the Continued Development and Growth of the Regions
SEATTLE, Oct. 15, 2020 /PRNewswire/ -- AGC Biologics, a leading global biopharmaceutical contract development and manufacturing organization (CDMO), has announced a leadership update atthe United States and Copenhagen facilities. The changes are being made to strengthen the strategic development ...
Thrive Bioscience Launches the CellAssist to Provide Imaging, Analytics, and Documentation for Reproducible Cell Culture
WAKEFIELD, Massachusetts, Oct. 15, 2020 /PRNewswire/ -- Thrive Bioscience introduces the CellAssist® which enables cell culture researchers to image, analyze, and document all cells, plates, reagents, and workflow details in a centralized database. The CellAssist was developed by Thrive Biosci...
Antengene Announces Collaboration with WuXi Biologics to Advance the Development of Innovative Oncology Medicines
SHANGHAI, Oct. 10, 2020 /PRNewswire/ -- Antengene Corporation, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, and WuXi Biologics ("WuXi Bio") (2269.HK) a...
Innovent Announces the Appointment of Dr. Yong Jun Liu as the President of the Group
SAN FRANCISCO and SUZHOU, China, Oct. 15, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
CUREMARK Honored by Goldman Sachs for Entrepreneurship
Dr. Joan M. Fallon, CEO and Founder Among 100 Most Intriguing Entrepreneurs at 2020 Builders + Innovators Summit RYE BROOK, New York, Oct. 15, 2020 /PRNewswire/ -- Goldman Sachs (NYSE: GS) is recognizing Curemark's Founder and CEO Dr.Joan M. Fallon as one of the 100 Most Intriguing Entrepreneur...
VolitionRx Limited Announces Details for Virtual Capital Markets Day 2020
AUSTIN, Texas, Oct. 14, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, announced further d...
SK Biopharmaceuticals, Ono Pharmaceutical Enter Licensing Agreement for Cenobamate in Japan
PANGYO, Gyeonggi Province, Korea, Oct. 13, 2020 /PRNewswire/ -- SK Biopharmaceuticals and Ono Pharmaceutical announced that they have entered into an exclusive licensing agreement for Ono to develop and commercialize cenobamate inJapan. Cenobamate is a treatment for partial-onset seizures (POS) ...
Kanaph Therapeutics Closes 21M USD Series B Funding
SEOUL, South Korea, Oct. 12, 2020 /PRNewswire/ -- Kanaph Therapeutics, a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules, recently completed their Series B funding of21M USD in South Korea. In this round, a large Korean pharma company, GC Pharma...
AGC Biologics Appoints Luca Alberici as the New General Manager/Site Head of the Milan, Italy Site
SEATTLE, Oct. 12, 2020 /PRNewswire/ -- AGC Biologics, a leading global biopharmaceutical contract development and manufacturing organization (CDMO), has announced a new appointment to initiate integration efforts resulting from theJuly 31, 2020 acquisition of MolMed, a biotechnology company focus...
Antengene's New Drug Discovery Center Established in Zhangjiang, Shanghai: Dedicated to the Research and Development of Innovative Therapies for Cancer
SHANGHAI, Oct. 12, 2020 /PRNewswire/ -- Antengene Corporation, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapies in oncology and hematology, announced today, the official opening of the Ant...
Enrolment of First Two Patients in PRISTINE Study with SELUTION SLR™ Sirolimus Drug Eluting Balloon
NYON, Switzerland, Oct. 12, 2020 /PRNewswire/ -- MedAlliance has announced enrolment of the first two patients in the PRISTINE registry with SELUTION SLR™ 018 DEB for the treatment of patients with Below The Knee disease (Chronic Limb Threatening Ischemia). This is the first DEB accepted by the F...
Gannex Received U.S. IND Approval for Its NASH Drug Candidate ASC42,an FXR Agonist
SHANGHAI, Oct. 12, 2020 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672) announces today that it received investigational new drug application (IND) approval from FDA for its drug candidate ASC42, to conduct clinical trials for non-alcoholic ste...
Gannex Received U.S. IND Approval for Its NASH Drug Candidate ASC42,an FXR Agonist
SHANGHAI, Oct. 11, 2020 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672) announces today that it received investigational new drug application (IND) approval from FDA for its drug candidate ASC42, to conduct clinical trials for non-alcoholic ste...
Innovent and Lilly Jointly Announce the NMPA Granted Marketing Approval for HALPRYZA® (Rituximab Injection) in China
SAN FRANCISCO and SUZHOU, China, Oct. 9, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major disease...
Ascentage Pharma's Apoptosis-Targeting Drug Candidates Granted Two More Orphan Drug Designations by the US FDA
SUZHOU, China and ROCKVILLE, MD., Oct. 9, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug Adm...
Foresee Pharmaceuticals Announces NDA for CAMCEVI(TM) 42MG Accepted for Review by the FDA
TAIPEI, Oct. 8, 2020 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee") announced today that the 505(b)(2) New Drug Application (NDA) for FP-001 LMIS 50mg, or CAMCEVI™ 42MG, a ready-to-use 6-month depot formulation of leuprolide mesylate, has been accepted for review by the ...
EB Research Partnership and EB Research Foundation Come Together as Largest Global Organization Advancing Research for Epidermolysis Bullosa
As the leading EB research funders worldwide, the group will combine to leverage EBRP's innovative business model to accelerate treatments and cures NEW YORK and MELBOURNE, Australia, Oct. 9, 2020 /PRNewswire/ -- EB Research Partnership (EBRP), based inNew York, and EB Research Foundation (EBRF) ...
Merck Celebrates Topping-Out Ceremony for New Membrane Production Plant
- Membrane manufacturing facility for aseptic filters will help meet customer demand in the growing biopharmaceutical market - Investment of more than € 140 million creates approximately 55 new jobs - Construction expected to be completed in 2022 DARMSTADT, Germany, Oct. 8, 2020 /PRNewswire/ --...
ITRI's Tech Innovation for COVID-19 Featured on Discovery Channel
TAIPEI, Oct. 8, 2020 /PRNewswire/ -- "Taiwan Revealed", a TV documentary series produced by Discovery Channel, premiered today inTaipei, highlighting Taiwan's technological innovations including the iPMx Molecular Rapid Test System developed byIndustrial Technology Research Institute(ITRI) <...
Milu Labs Wins Major Female-Focused Tech Competition in Thailand
BANGKOK, Oct. 8, 2020 /PRNewswire/ -- Milu Labs, an innovative biotech company
focused exclusively on women's health, has won 1st place in the She Loves Tech
Thailand startup competition.
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00